1 |
313 |
hsa-mir-221
|
Muscular |
Muscular |
muscle |
17942673 |
MI0000298 |
up |
Patient study phenotype-control |
2 |
80 |
hsa-mir-221
|
Hepatocellular carcinoma |
Cancer |
liver |
17616664 |
MI0000298 |
up |
Patient study phenotype-phenotype |
3 |
488 |
hsa-mir-221
|
Prostate cancer |
Cancer |
Tsu-Pr1 cell |
16192569 |
MI0000298 |
down |
Cell culture study |
4 |
493 |
hsa-mir-221
|
Squamous cell carcinoma, head and neck |
Cancer |
squamous cell carcinoma cell line |
16192569 |
MI0000298 |
down |
Cell culture study |
5 |
322 |
hsa-mir-221
|
Hepatocellular carcinoma |
Cancer |
SNU-423 cell |
18555017 |
MI0000298 |
up |
Cell culture study |
6 |
98 |
hsa-mir-221
|
Gastric cancer |
Cancer |
stomach |
18328430 |
MI0000298 |
up |
Patient study phenotype-control |
7 |
102 |
hsa-mir-221
|
Thyroid carcinoma, follicular |
Cancer |
thyroid gland |
18270258 |
MI0000298 |
up |
Patient study phenotype-control |
8 |
503 |
hsa-mir-221
|
Lung cancer |
Cancer |
serum |
18766170 |
MI0000298 |
up |
Patient study phenotype-control |
9 |
106 |
hsa-mir-221
|
Colorectal cancer |
Cancer |
colorectum |
16461460 |
MI0000298 |
up |
Patient study phenotype-control |
10 |
507 |
hsa-mir-221
|
Gastrointestinal |
Gastrointestinal |
pancreas |
19030927 |
MI0000298 |
up |
Patient study phenotype-control |
11 |
360 |
hsa-mir-221
|
|
|
blood |
17976518 |
MI0000298 |
down |
Bioprocess study |
12 |
120 |
hsa-mir-221
|
Gastric cancer |
Cancer |
stomach |
16461460 |
MI0000298 |
up |
Patient study phenotype-control |
13 |
524 |
hsa-mir-221
|
Pancreatic cancer |
Cancer |
PANC-1 cell |
16192569 |
MI0000298 |
down |
Cell culture study |
14 |
2 |
hsa-mir-221
|
Pancreatic cancer |
Cancer |
pancreatic duct |
17149698 |
MI0000298 |
up |
Patient study phenotype-control |
15 |
386 |
hsa-mir-221
|
Leukemia, acute myeloid |
Cancer |
bone marrow |
18337557 |
MI0000298 |
down |
Patient study phenotype-phenotype |
16 |
144 |
hsa-mir-221
|
Alzheimer disease, susceptibility to |
Neurological |
cerebrospinal fluid |
18525125 |
MI0000298 |
down |
Patient study phenotype-phenotype |
17 |
531 |
hsa-mir-221
|
Hematological |
Hematological |
K-562 cell |
16192569 |
MI0000298 |
down |
Cell culture study |
18 |
5 |
hsa-mir-221
|
Thyroid carcinoma, papillary |
Cancer |
thyroid gland |
16728577 |
MI0000298 |
up |
Patient study phenotype-control |
19 |
402 |
hsa-mir-221
|
Hepatocellular carcinoma |
Cancer |
liver |
18223217 |
MI0000298 |
up |
Patient study phenotype-control |
20 |
179 |
hsa-mir-221
|
Cancer |
Cancer |
blood |
18923441 |
MI0000298 |
down |
Patient study phenotype-control |
21 |
541 |
hsa-mir-221
|
|
|
placenta |
16330772 |
MI0000298 |
down |
Bioprocess study |
22 |
13 |
hsa-mir-221
|
Pancreatic cancer |
Cancer |
pancreatic duct |
17473300 |
MI0000298 |
up |
Patient study phenotype-control |
23 |
412 |
hsa-mir-221
|
Cardiomyopathy, idiopathic dilated |
Cardiovascular |
heart |
18582896 |
MI0000298 |
down |
Patient study phenotype-control |
24 |
203 |
hsa-mir-221
|
Neuroblastoma |
Cancer |
neuroblastoma cell |
17943719 |
MI0000298 |
up |
Patient study phenotype-phenotype |
25 |
545 |
hsa-mir-221
|
|
|
cell culture |
16482530 |
MI0000298 |
up |
Bioprocess study |
26 |
33 |
hsa-mir-221
|
Glioblastoma multiforme, somatic |
Cancer |
brain |
18759060 |
MI0000298 |
up |
Patient study phenotype-control |
27 |
451 |
hsa-mir-221
|
Breast cancer |
Cancer |
MCF-7 cell |
16192569 |
MI0000298 |
down |
Cell culture study |
28 |
254 |
hsa-mir-221
|
Leukemia, chronic lymphatic, susceptibility to |
Cancer |
blood |
16251535 |
MI0000298 |
up |
Patient study phenotype-phenotype |
29 |
601 |
hsa-mir-221
|
Hepatocellular carcinoma |
Cancer |
liver |
20018759 |
MI0000298 |
up |
Patient study phenotype-control |
30 |
67 |
hsa-mir-221
|
Hepatocellular carcinoma |
Cancer |
liver |
18319255 |
MI0000298 |
up |
Patient study phenotype-control |